Folate Receptor-Alpha Positive
3 clinical trials · Condition
◉ Watch Folate Receptor-Alpha Positive
| Record | Firm | Date |
|---|---|---|
| Mirvetuximab Soravtansine as First Line in Treating Patients With Triple Negative Breast Cancer (NCT03106077) | M.D. Anderson Cancer Center | 2017-06-05 |
Track Folate Receptor-Alpha Positive automatically
Every clearance here is in the API, with alerts when new ones post.